Galactose Supplementation for the Treatment of MOGHE

Clinical trial NCT04833322 · UNKNOWN

Trial details

NCT number: NCT04833322
Sponsor: Hospital Ruber Internacional
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Refractory Epilepsy SLC35A2-CDG - Solute Carrier Family 35 Member A2 Congenital Disorder of Glycosylation

Start date: 2021-01-15
Primary completion: 2021-09-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.